Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population
- PMID: 20368174
- DOI: 10.1126/scitranslmed.3000237
Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population
Abstract
Gout based on hyperuricemia is a common disease with a genetic predisposition, which causes acute arthritis. The ABCG2/BCRP gene, located in a gout-susceptibility locus on chromosome 4q, has been identified by recent genome-wide association studies of serum uric acid concentrations and gout. Urate transport assays demonstrated that ABCG2 is a high-capacity urate secretion transporter. Sequencing of the ABCG2 gene in 90 hyperuricemia patients revealed several nonfunctional ABCG2 mutations, including Q126X. Quantitative trait locus analysis of 739 individuals showed that a common dysfunctional variant of ABCG2, Q141K, increases serum uric acid. Q126X is assigned to the different disease haplotype from Q141K and increases gout risk, conferring an odds ratio of 5.97. Furthermore, 10% of gout patients (16 out of 159 cases) had genotype combinations resulting in more than 75% reduction of ABCG2 function (odds ratio, 25.8). Our findings indicate that nonfunctional variants of ABCG2 essentially block gut and renal urate excretion and cause gout.
Similar articles
-
ABCG2/BCRP dysfunction as a major cause of gout.Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1117-28. doi: 10.1080/15257770.2011.633954. Nucleosides Nucleotides Nucleic Acids. 2011. PMID: 22132966
-
Identification of ABCG2 dysfunction as a major factor contributing to gout.Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1098-104. doi: 10.1080/15257770.2011.627902. Nucleosides Nucleotides Nucleic Acids. 2011. PMID: 22132963
-
ABCG2 dysfunction increases the risk of renal overload hyperuricemia.Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):266-74. doi: 10.1080/15257770.2013.866679. Nucleosides Nucleotides Nucleic Acids. 2014. PMID: 24940678
-
[Recent progress and prospects for research on urate efflux transporter ABCG2].Nihon Rinsho. 2014 Apr;72(4):757-65. Nihon Rinsho. 2014. PMID: 24796111 Review. Japanese.
-
An update on the genetic architecture of hyperuricemia and gout.Arthritis Res Ther. 2015 Apr 10;17(1):98. doi: 10.1186/s13075-015-0609-2. Arthritis Res Ther. 2015. PMID: 25889045 Free PMC article. Review.
Cited by
-
Prediction and causal inference of hyperuricemia using gut microbiota.Sci Rep. 2024 Apr 30;14(1):9901. doi: 10.1038/s41598-024-60427-6. Sci Rep. 2024. PMID: 38688923 Free PMC article.
-
A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease.Cells. 2024 Mar 4;13(5):450. doi: 10.3390/cells13050450. Cells. 2024. PMID: 38474414 Free PMC article. Review.
-
Plasma and Urinary Metabolomic Analysis of Gout and Asymptomatic Hyperuricemia and Profiling of Potential Biomarkers: A Pilot Study.Biomedicines. 2024 Jan 27;12(2):300. doi: 10.3390/biomedicines12020300. Biomedicines. 2024. PMID: 38397902 Free PMC article.
-
Examining the Association of Rare Allelic Variants in Urate Transporters SLC22A11, SLC22A13, and SLC17A1 with Hyperuricemia and Gout.Dis Markers. 2024 Jan 6;2024:5930566. doi: 10.1155/2024/5930566. eCollection 2024. Dis Markers. 2024. PMID: 38222853 Free PMC article.
-
Dysuricemia.Biomedicines. 2023 Nov 28;11(12):3169. doi: 10.3390/biomedicines11123169. Biomedicines. 2023. PMID: 38137389 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases